Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide.

PropertyValue
has major subject area list Antineoplastic Combined Chemotherapy Protocols; Cognitive Dysfunction; Cyclophosphamide; Docetaxel; Doxorubicin
information resource reference Brown T, McElroy T, Simmons P, Walters H, Ntagwabira F, Wang J, Byrum SD, Allen AR. Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide. Brain Res. 2021 06 01; 1760:147397.
label Cognitive impairment resulting from treatment with docetaxel, doxorubicin, and cyclophosphamide.

Search Criteria
  • Doxorubicin